John G. Ullman & Associates’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,210
| Closed | -$554K | – | 182 |
|
|
2025
Q4 | $554K | Hold |
2,210
| – | – | 0.07% | 124 |
|
|
2025
Q3 | $634K | Sell |
2,210
-100
| -4% | -$26.8K | 0.09% | 116 |
|
|
2025
Q2 | $606K | Hold |
2,310
| – | – | 0.09% | 116 |
|
|
2025
Q1 | $538K | Sell |
2,310
-41
| -2% | -$9.95K | 0.08% | 129 |
|
|
2024
Q4 | $539K | Sell |
2,351
-13
| -0.5% | -$2.98K | 0.08% | 125 |
|
|
2024
Q3 | $528K | Hold |
2,364
| – | – | 0.08% | 131 |
|
|
2024
Q2 | $481K | Buy |
2,364
+32
| +1% | +$6.51K | 0.07% | 134 |
|
|
2024
Q1 | $509K | Hold |
2,332
| – | – | 0.08% | 124 |
|
|
2023
Q4 | $530K | Buy |
2,332
+8
| +0.3% | +$1.68K | 0.08% | 120 |
|
|
2023
Q3 | $467K | Sell |
2,324
-614
| -21% | -$130K | 0.08% | 124 |
|
|
2023
Q2 | $609K | Hold |
2,938
| – | – | 0.09% | 125 |
|
|
2023
Q1 | $579K | Hold |
2,938
| – | – | 0.09% | 124 |
|
|
2022
Q4 | $594K | Hold |
2,938
| – | – | 0.09% | 112 |
|
|
2022
Q3 | $517K | Hold |
2,938
| – | – | 0.09% | 113 |
|
|
2022
Q2 | $592K | Sell |
2,938
-3
| -0.1% | -$639 | 0.1% | 110 |
|
|
2022
Q1 | $666K | Buy |
2,941
+1
| +0% | +$235 | 0.09% | 108 |
|
|
2021
Q4 | $794K | Buy |
2,940
+2
| +0.1% | +$495 | 0.11% | 96 |
|
|
2021
Q3 | $710K | Sell |
2,938
-233
| -7% | -$58.7K | 0.1% | 97 |
|
|
2021
Q2 | $751K | Sell |
3,171
-107
| -3% | -$24.4K | 0.1% | 95 |
|
|
2021
Q1 | $718K | Buy |
3,278
+107
| +3% | +$21.5K | 0.1% | 93 |
|
|
2020
Q4 | $554K | Sell |
3,171
-116
| -4% | -$20K | 0.09% | 97 |
|
|
2020
Q3 | $532K | Hold |
3,287
| – | – | 0.11% | 77 |
|
|
2020
Q2 | $469K | Hold |
3,287
| – | – | 0.11% | 69 |
|
|
2020
Q1 | $357K | Hold |
3,287
| – | – | 0.09% | 81 |
|
|
2019
Q4 | $478K | Hold |
3,287
| – | – | 0.08% | 104 |
|
|
2019
Q3 | $474K | Sell |
3,287
-466
| -12% | -$68K | 0.09% | 94 |
|
|
2019
Q2 | $557K | Sell |
3,753
-156
| -4% | -$21.8K | 0.1% | 88 |
|
|
2019
Q1 | $514K | Buy |
3,909
+717
| +22% | +$88.3K | 0.09% | 86 |
|
|
2018
Q4 | $346K | Sell |
3,192
-58
| -2% | -$7.77K | 0.07% | 100 |
|
|
2018
Q3 | $485K | Hold |
3,250
| – | – | 0.09% | 88 |
|
|
2018
Q2 | $501K | Hold |
3,250
| – | – | 0.09% | 79 |
|
|
2018
Q1 | $452K | Hold |
3,250
| – | – | 0.09% | 83 |
|
|
2017
Q4 | $445K | Hold |
3,250
| – | – | 0.09% | 87 |
|
|
2017
Q3 | $422K | Sell |
3,250
-116
| -3% | -$15.5K | 0.08% | 86 |
|
|
2017
Q2 | $446K | Buy |
3,366
+137
| +4% | +$16.8K | 0.09% | 90 |
|
|
2017
Q1 | $398K | Buy |
+3,229
| New | +$382K | 0.08% | 93 |
|
Other funds holding LH
VCM
VPM
John G. Ullman & Associates's LH Position: Q1 2026 in Review
John G. Ullman & Associates sold out of Labcorp (LH) in Q1 2026, closing a stake of 2,210 shares — an estimated $554K sold.
John G. Ullman & Associates first reported a position in LH in Q1 2017 and held it in 36 quarters. The position peaked at $794K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- John G. Ullman & Associates reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
- John G. Ullman & Associates sold 2,210 Labcorp shares in Q1 2026, an estimated $554K.
- John G. Ullman & Associates first reported a position in Labcorp in Q1 2017 and held it in 36 quarters.
- John G. Ullman & Associates's Labcorp position peaked at $794K in Q4 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on John G. Ullman & Associates's 13F filing for Q1 2026, filed 6 May 2026.